Related Experiment Video
Updated: Nov 8, 2025

Functional Characterization of Carboxylesterases in Insecticide Resistant House Flies, Musca Domestica
Published on: August 23, 2018
Small-molecule inhibitors of carboxylesterase Notum
Yuguang Zhao1, Sarah Jolly2, Stefano Benvegnu2
1Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Henry Wellcome Building for Genomic Medicine, Roosevelt Drive, Oxford, OX3 7BN, UK.
Abstract:
Notum has recently been identified as a negative regulator of Wnt signaling through the removal of an essential palmitoleate group from Wnt proteins. There are emerging reports that Notum plays a role in human disease, with published data suggesting that targeting Notum could represent a new therapeutic approach for treating cancer, osteoporosis and neurodegenerative disorders. Complementary hit-finding strategies have been applied with successful approaches that include high-throughput screening, activity-based protein profiling, screening of fragment libraries and virtual screening campaigns. Structural studies are accelerating the discovery of new inhibitors of Notum. Three fit-for-purpose examples are LP-922056, ABC99 and ARUK3001185. The application of these small-molecule inhibitors is helping to further advance an understanding of the role Notum plays in human disease.
Insights
Notum negatively regulates Wnt signaling by removing a palmitoleate group from Wnt proteins. Inhibiting Notum offers a potential therapeutic strategy for cancer, osteoporosis, and neurodegenerative diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Notum is identified as a negative regulator of Wnt signaling.
- It functions by removing a palmitoleate group from Wnt proteins.
- Emerging evidence links Notum to human diseases like cancer, osteoporosis, and neurodegenerative disorders.
Purpose of the Study:
- To explore the role of Notum in human diseases.
- To identify and develop small-molecule inhibitors of Notum.
- To advance the understanding of Notum's function and therapeutic potential.
Main Methods:
- High-throughput screening
- Activity-based protein profiling
- Fragment library screening
- Virtual screening campaigns
- Structural studies
Main Results:
- Several hit-finding strategies were successfully applied.
- Structural studies are facilitating the discovery of Notum inhibitors.
- Specific inhibitors like LP-922056, ABC99, and ARUK3001185 have been identified.
Conclusions:
- Targeting Notum presents a novel therapeutic avenue for various human diseases.
- Small-molecule inhibitors of Notum are crucial tools for further research.
- Continued investigation will deepen the understanding of Notum's role in disease pathogenesis.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Enzyme Inhibition
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
Carboxylic Acids to Esters: Acid-Catalyzed (Fischer) Esterification Mechanism
Esters to Carboxylic Acids: Saponification
The reaction requires a base in stoichiometric amounts, which participates in the reaction and is not regenerated later. So, the base acts as a...

